US Physical Therapy Files 8-K
Ticker: USPH · Form: 8-K · Filed: Nov 12, 2024 · CIK: 885978
Sentiment: neutral
Topics: regulatory-filing, 8-k
Related Tickers: USPHY
TL;DR
USPHY filed an 8-K, standard reporting, no new info.
AI Summary
U.S. Physical Therapy, Inc. filed an 8-K on November 12, 2024, to report information under Regulation FD and to file financial statements and exhibits. The filing does not appear to contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates U.S. Physical Therapy is meeting its regulatory reporting obligations. It does not disclose new material information that would immediately impact investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for regulatory compliance and does not contain any new material adverse information.
Key Players & Entities
- U.S. PHYSICAL THERAPY, INC. (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- 713-297-7000 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report information under Regulation FD and to file financial statements and exhibits.
What is the exact name of the registrant?
The exact name of the registrant is U.S. PHYSICAL THERAPY, INC.
In which state is U.S. Physical Therapy, Inc. incorporated?
U.S. Physical Therapy, Inc. is incorporated in Nevada.
What is the principal executive office address?
The principal executive office address is 1300 WEST SAM HOUSTON PARKWAY, SUITE 300, HOUSTON, Texas 77043.
What is the filing date of this report?
The date of the report, and the earliest event reported, is November 12, 2024.
Filing Stats: 558 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-11-12 16:07:36
Filing Documents
- form8-k.htm (8-K) — 33KB
- ex99-1.htm (EX-99.1) — 5KB
- logo_usph2020.jpg (GRAPHIC) — 370KB
- 0000885978-24-000066.txt ( ) — 672KB
- usph-20241112.xsd (EX-101.SCH) — 4KB
- usph-20241112_lab.xml (EX-101.LAB) — 21KB
- usph-20241112_pre.xml (EX-101.PRE) — 16KB
- form8-k_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
ITEM 7.01 Regulation FD Disclosure. On November 12, 2024 – U.S. Physical Therapy, Inc. (the "Company) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that Chris Reading, Chief Executive Officer, will participate in the Stephens Annual Investment Conference on Wednesday, November 20, 2024. On the same day, Carey Hendrickson, Chief Financial Officer, will present at the 16th Annual Southwest IDEAS Conference. The presentations will cover an overview of the Company. A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Current Report on Form 8-K, including the exhibits, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibits Description of Exhibits 99.1 Registrant's Press Release dated November 12, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. U.S. PHYSICAL THERAPY, INC. Dated: November 12, 2024 By: /s/ CAREY HENDRICKSON Carey Hendrickson Chief Financial Officer (duly authorized officer and principal financial and accounting officer)